Skip to main content
Clinical Trials/NCT04853940
NCT04853940
Completed
Not Applicable

Respiratory Muscle Function, Dyspnea, Exercise Capacity and Quality of Life in Severe COVID19 Patients After ICU Discharge: a 6 Months Follow-up Observational Study

ConditionsCovid19

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Covid19
Sponsor
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Enrollment
50
Locations
1
Primary Endpoint
Maximal Inspiratory Pressure (MIP) (centimetres of water, cmH20)
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Further knowledge regarding sequelae in severe COVID-19 patients who have required ICU admission for invasive mechanical ventilation is still needed. Available evidence suggests ongoing respiratory impairment and impact in quality of life.

Detailed Description

PURPOSE: To evaluate post-ICU clinical outcomes in severe COVID-19 ICU survivors. DESIGN: A prospective observational study conducted in public hospital in Madrid, Spain. METHODS: Participants: patients diagnosed with severe COVID-19 who have survived ICU admission for invasive mechanical ventilation and have been discharged from hospital. Intervention: Patients will be invited to attend follow-up visits at the hospital for assessments 3 months and 6 months after ICU discharge. Outcome measures: Tests of respiratory muscles function will include ultrasonography of the diaphragm muscle to measure diaphragm thickness (DT), diaphragm thickening ratio (TR) and diaphragm excursion (DE); respiratory muscle strength measurement to obtain Maximal Inspiratory Pressure (MIP), Maximal Expiratory Pressure (MEP) and Maximal Sniff Nasal Inspiratory Pressure (SNIP); functional exercise capacity will be assessed with the Six Minutes Walk Test (6MWT); dyspnea and health-related quality of life will be evaluated with the Modified Medical Research Council Scale (mMRC Scale) and the Saint George's Respiratory Questionnaire (SGRQ). Data on participants' demographics and clinical data will also be collected. Statistical Analysis: Descriptive statistics will be used to summarise data. Spearman's correlation coefficients will be used to explore associations between variables. CONCLUSIONS AND SIGNIFICANCE OF THE RESEARCH: Understanding post-ICU clinical outcomes in patients with severe COVID-19 may help develop future prevention, therapeutic and follow-up strategies that improve quality of care and outcomes

Registry
clinicaltrials.gov
Start Date
January 1, 2021
End Date
January 1, 2022
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Maria Natividad Seisdedos Nunez

Senior Physiotherapist, MSc

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

Eligibility Criteria

Inclusion Criteria

  • ⋧18 years old,
  • subjects diagnosed with COVID-19 confirmed by positive SARS-CoV-2 PCR testing who require admission to ICU for invasive mechanical ventilation
  • invasive ventilation \> 24 hours.

Exclusion Criteria

  • pre-existing cognitive impairment,
  • communication/language barrier
  • any concurrent physical or mental health condition/ impairment that prevents subjects from taking part in evaluations or providing informed consent
  • loss of independent walking ability (with or without walking aids) prior to hospitalisation defined by a score of ≤2 on the mobility item of the modified Barthel Index,
  • pregnancy,
  • any injuries/surgery that requires medical bed rest.

Outcomes

Primary Outcomes

Maximal Inspiratory Pressure (MIP) (centimetres of water, cmH20)

Time Frame: within 6 months after ICU discharge

It is the greater pressure which may be generated during maximal inspiration by the inspiratory muscles.

Secondary Outcomes

  • Diaphragm Thickening Ratio during quiet breathing (centimetres)(within 6 months after ICU discharge)
  • Saint George's Respiratory Questionnaire (SGRQ) score(within 6 months following ICU dischargemonths following ICU discharge)
  • Diaphragm Thickening Ratio during deep breathing (centimetres)(within 6 months after ICU discharge)
  • Modified Medical Research Council (mMRC) Dyspnea score(within 6 months following ICU discharge)
  • Maximal Expiratory Pressure (MEP) (cmH20)(within 6 months after ICU discharge)
  • 6-Minutes Walk Test (6MWT) (metres)(within 6 months following ICU discharge)
  • Diaphragm Excursion during deep breathing (centimetres)(within 6 months after ICU discharge)

Study Sites (1)

Loading locations...

Similar Trials